News archive - Page 12 of 25

Advancement in Metabolic dysfunction-Associated SteatoHepatitis (MASH) treatment: the first FDA approved drug

May 21, 2024 By Editorial Staff In Biology, Pharmacology, R&D

The FDA approves Madrigal Pharmaceuticals’ Rezdiffra for Metabolic dysfunction-Associated SteatoHepatitis (MASH), previously known as NASH, marking a milestone in treating fatty liver disease. Rezdiffra targets lipid metabolism and shows promising results in clinical trials. The first line tre...

Health Innovation Global Forum

May 01, 2024 By Editorial Staff In Events

MIND, 9 MAY 2024 – Auditorium Human Technopole – Viale Rita Levi-Montalcini, 1, 20157 The availability of new technologies in the study of biological mechanisms has opened up new perspectives and deepened the understanding of biological processes, a better definition of morbid conditions...

Unprecedented blood biomarker enables ALS drug approval

April 29, 2024 By Editorial Staff In Biology, R&D

Biogen’s Qalsody (tofersen) has been approved by the US Food and Drug Administration (FDA) for treating a rare form of amyotrophic lateral sclerosis (ALS). This is a good news for the small number of patients, affected by a genetically defined form of ALS, expected to access the antisense drug. Mo...

First amniotic fluid-derived human organoids will advance prenatal precision medicine in a new era.

April 29, 2024 By Editorial Staff In Biology, Pharmacology, R&D, Technologies

Researchers created 3D models of developing organs from fetal cells, which are present in amniotic fluid, to help prenatal diagnosis and speed up innovative therapeutic strategies in rare diseases. Congenital disorders, according to WHO (World Health Organization), affect 6% of newborns globally, ca...

Meeting Points Between Research, Industry, and the Crucial Role of Tech Transfer. The new event branded ITTBioMed

April 04, 2024 By Editorial Staff In Biology, Events, Technologies

On March 26th, in Milan, the event “Patents and Secrets: Technology Transfer in Life Sciences” organized by ITTBioMed of Edra and DLA Piper took place, with the support of Lendlease, MIND, and T-Factor. In the field of biotechnology, technology transfer (Tech Transfer) emerges as an esse...

Immunotherapy and cell-based immunotherapy: TILs on stage

April 04, 2024 By Editorial Staff In Biology, Pharmacology, R&D

CAR-T therapy is one of the most revolutionary approaches of these years, but Tumor-infiltrating lymphocytes (TILs) are taking the stage for the treatment of solid tumor...

1 2 3 4 5 … 7 8 9 10 11 12 13 14 15 16 17 … 21 22 23 24 25